Skip to main content
. 2020 Nov 15;21(22):8605. doi: 10.3390/ijms21228605

Figure 7.

Figure 7

Schematic depiction of the operating mechanism of redox-responsive antimicrobial nanosystems consisting of disulfide modified MSNs loaded with moxifloxacin (MXF) and end-capped with β-cyclodextrin (β-CD) throughout a disulfide linker. Adapted from ref. [91]. The exposition to reducing milieu in bacteria (e.g. glutathione or 2-mercaptoethanol) triggers the cleavage of disulfide bond, which allows pore uncapping and cargo release.